Biotech industry is buoyant and booming

05 Jul 2018

This is the eighth Biotechnology Industry Position Survey conducted by AusBiotech and supported by Grant Thornton. The 2018 Survey reveals the strongest ever business sentiment across the sector.

The number who described the environment as conducive to growing a biotechnology company has almost returned to 2016 levels after a fall last year in response to uncertainty over the future of the R&D Tax Incentive.

The return of more positive sentiment towards the environment also comes as the recent announcement in the 2018-19 Budget of changes to the R&D Tax Incentive exempted investment in clinical trials from the new $4 million annual cap on the refundable component.

Key findings in the report include:

Biotech booming
Value of clinical trials recognised and supported
Snapshot shows a larger sector than expected
Skills and talent attraction looms as significant issue

Download PDF

Download PDF [2627 kb]

77% of respondents described the past twelve months as an ‘excellent’ or ‘good’ year, up from 72 percent in the 2017 survey.

Almost 90 percent of respondents said they expect to grow in 2018.

Play Video

Sky Business News interview on 2018 Biotechnology Industry Position Survey

Watch Michael Cunningham, National Head of Life Sciences for Grant Thornton and AusBiotech CEO Lorraine Chiroiu talk on Sky Business News about the opportunities and challenges facing Australia’s Biotech industry.